I wonder if his expertise in the field is going to be called upon for Cellpryme as it’s nearing its first deal?
- Forums
- ASX - By Stock
- PTX
- Ann: March 2023 Quarterly Update and Appendix 4C
Ann: March 2023 Quarterly Update and Appendix 4C, page-19
Featured News
Add PTX (ASX) to my watchlist
|
|||||
Last
4.0¢ |
Change
-0.001(2.44%) |
Mkt cap ! $32.21M |
Open | High | Low | Value | Volume |
3.9¢ | 4.0¢ | 3.9¢ | $35.17K | 896.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 350000 | 3.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.0¢ | 163887 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 350000 | 0.039 |
14 | 1769182 | 0.038 |
2 | 127000 | 0.037 |
7 | 588946 | 0.036 |
5 | 323576 | 0.035 |
Price($) | Vol. | No. |
---|---|---|
0.040 | 163887 | 2 |
0.041 | 116157 | 2 |
0.042 | 180000 | 2 |
0.043 | 300000 | 2 |
0.044 | 107692 | 2 |
Last trade - 16.10pm 26/06/2024 (20 minute delay) ? |
Featured News
PTX (ASX) Chart |